FDA Adverse Event Malfunction Summary report: N

LS LF MB EXT SET CLAVE LSC T

MDR report key: 2910056 · Received November 19, 2012

Report

Report Number
9613251-2012-00225
Event Type
Malfunction
Date Received
November 19, 2012
Date of Event
September 6, 2012
Report Date
October 25, 2012
Manufacturer
HOSPIRA LTD.
Product Code
FPA
PMA / PMN Number
K030002
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
RISK MANAGER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE CUSTOMER INDICATED THE DEVICE WAS DISCARDED. THE DEVICE WAS NOT RETURNED TO HOSPIRA FOR TESTING AND INVESTIGATION; THEREFORE, ATTRIBUTION OF THE ISSUE TO THE DEVICE COULD NOT BE DETERMINED. THIS REPORT REPRESENTS ALL THE INFORMATION KNOWN BY THE REPORTER UPON QUERY BY HOSPIRA PERSONNEL.

Description of Event or Problem · 1

UPON FURTHER QUERY, THE CUSTOMER CONTACT REPORTED A SEPARATION. THE TUBING SET WAS BEING USED TO DELIVER AN UNSPECIFIED MEDICATION. THE CUSTOMER CONTACT REPORTED THAT AFTER THE PT WAS REPOSITIONED ONTO THE PT'S BACK FOLLOWING THE PROCEDURE, THE TUBING HAD SEPARATED AT AN UNSPECIFIED LOCATION OF THE TUBING SET. IT WAS REPORTED THAT UNSPECIFIED VOLUME OF SOLUTION LEAKED AND AN UNSPECIFIED VOLUME OF BLOOD LOSS WAS NOTED. THE TUBING SET WAS REPLACED AND THE THERAPY WAS RESUMED. THERE WERE NO REPORTED ADVERSE PT EFFECTS AND NO REPORTED DELAY OF THERAPY CRITICAL TO THIS PT. NO MEDICAL INTERVENTION WERE REQUIRED. THOUGH REQUESTED, NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LS LF MB EXT SET CLAVE LSC T 80FPA FPA HOSPIRA LTD. NA 71075NS

Patients

Seq Age Sex Outcome Treatment
1